Zoetis Inc
ZTSView Detailed Chart
149.440USD
+2.480+1.69%
Close 04/11, 16:00(ET)Quotes delayed by 15 min
67.02BMarket Cap
26.96P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+1.69%
5 Days
-1.51%
1 Month
-6.64%
6 Months
-21.38%
Year to Date
-8.28%
1 Year
-0.36%
View Detailed Chart
Agency Rating
Analyst Rating
Based on
20
analysts
BUY
Current Rating
203.369
Target Price
36.09%
Rising Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
160
Total
6
Median
8
Average
Company name
Ratings
Analysts
Zoetis Inc
ZTS
20
Biogen Inc
BIIB
37
Vertex Pharmaceuticals Inc
VRTX
34
Alnylam Pharmaceuticals Inc
ALNY
33
Amgen Inc
AMGN
33
Gilead Sciences Inc
GILD
30
1
2
3
...
32
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Sell
Indicators
Indicators
Value
Direction
MACD(12,26,9)
-2.675
Sell
RSI(14)
39.142
Neutral
STOCH(KDJ)(9,3,3)
33.500
Neutral
ATR(14)
6.481
High Vlolatility
CCI(14)
-86.469
Neutral
Williams %R
63.326
Sell
TRIX(12,20)
-0.350
Sell
StochRSI(14)
84.854
Overbought
Moving Average
Indicators
Value
Direction
MA5
148.712
Buy
MA10
154.496
Sell
MA20
158.996
Sell
MA50
163.701
Sell
MA100
167.164
Sell
MA200
175.585
Sell
News
More news coming soon, stay tuned...
Company
Zoetis Inc. is a global animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The Company operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. It directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. The Company is engaged in commercializing products across eight species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).
Company codeZTS
CompanyZoetis Inc
CEOMs. Kristin C. Peck
Websitehttps://www.zoetis.com/
Related Instruments

+1.53%
+1.98%
+0.48%
+5.77%
+3.97%
+2.19%
+1.97%
+1.62%
+2.20%
+3.71%
+1.84%
+1.46%
+0.47%
+1.55%
+3.05%
+1.53%
+1.98%
+0.48%
+5.77%
+3.97%
+2.19%
+1.97%
+1.62%
+2.20%
+3.71%
+1.84%
+1.46%
+0.47%
+1.55%
+3.05%